| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 07/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 08/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 03/11/2004 |
| Director/Board Member | 52 | 31/01/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 31/12/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| +0.25% | -0.22% | +68.73% | +116.60% | 1,052B | |
| +0.78% | +1.21% | +48.53% | +52.20% | 627B | |
| +0.35% | +1.74% | +21.11% | +65.18% | 441B | |
| +0.28% | -3.05% | +39.10% | +36.65% | 349B | |
| +0.78% | -2.05% | +24.03% | +36.97% | 287B | |
| +0.87% | -2.82% | -0.28% | +6.27% | 241B | |
| +1.00% | +2.05% | +41.46% | +58.24% | 224B | |
| -0.78% | -4.16% | -10.28% | -53.87% | 202B | |
| +0.40% | +4.29% | +17.36% | +78.10% | 172B | |
| Average | +0.39% | -0.77% | +27.75% | +44.04% | 399.46B | |
| Weighted average by Cap. | +0.29% | -0.63% | +39.71% | +62.49% |
Employees
18
Sector
Pharmaceuticals
